Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease: An international study in non-cirrhotic, biopsy-proven patients

被引：1

作者：

Younes, Ramy ^{[1
]}

Rosso, Chiara ^{[1
]}

Garcia Blanco, Maria Jose ^{[2
]}

Petta, Salvatore ^{[3
]}

Miele, Luca ^{[4
]}

Liguori, Antonio ^{[4
]}

Francione, Paolo ^{[5
]}

Fracanzani, Anna Ludovica ^{[5
]}

Valenti, Luca ^{[6
]}

Anstee, Quentin ^{[7
]}

Bugianesi, Elisabetta ^{[1
]}

机构：

[1] Univ Turin, Dept Med Sci, Div Gastroenterol & Hepatol, Turin, Italy

[2] Univ Hosp La Princesa, Dept Internal Med, Madrid, Spain

[3] Univ Palermo, Sez Gastroenterol, Di Bi MIS, Palermo, Italy

[4] Univ Cattolica S Cuore, Fdn Policlin Univ A Gemelli IRCCS, Area Gastroenterol & Oncol Med, Rome, Italy

[5] Univ Milan, Policlin Hosp, Ca Granda IRCCS Fdn, Metab Liver Dis Res Ctr,Dept Pathophysiol & Trans, Milan, Italy

[6] Univ Milan, Policlin Hosp, Dept Transfus Med & Hematol, Translat Med & Hepatol, Milan, Italy

[7] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30239-7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS-205

引用

页码：E136 / E137

页数：2

共 50 条

[1] Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease. An international study in non-cirrhotic, biopsy-proven patients
Younes, R.
Rosso, C.
Garcia Blanco, M. J.
Petta, S.
Miele, L.
Liguori, A.
Francione, P.
Fracanzani, A.
Valenti, L.
Anstee, Q. M.
Bugianesi, E.
[J]. DIGESTIVE AND LIVER DISEASE, 2019, 51 : E5 - E5
[2] EXERCISE BEHAVIOR IN PATIENTS WITH BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE
Glass, Oliver
Wang, Ying
Liu, Daniel
Guy, Cynthia D.
Diehl, Anna Mae
Abdelmalek, Manal F.
[J]. HEPATOLOGY, 2019, 70 : 748A - 748A
[3] Incidence of Non-Alcoholic Fatty Liver Disease in Patients With Biopsy-Proven Celiac Disease
Shah, Apeksha
Wong, She-Yan
Janowski, Raymond
Moleski, Stephanie M.
Halegoua-De Marzio, Dina
[J]. GASTROENTEROLOGY, 2016, 150 (04) : S1145 - S1145
[4] Validation of non-invasive fibrosis assessments in biopsy-proven non-alcoholic fatty liver disease
Drolz, A.
Wehmeyer, M.
Diedrich, T.
Wiesch, J. S. zur
Lohse, A. W.
Kluwe, J.
[J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S150 - S151
[5] Biopsy-proven Non-alcoholic Fatty Liver Disease and Incident Cancer
Kim, Hee Yeon
[J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2021, 78 (06): : 362 - 363
[6] Obstructive sleep apnoea is common in adults with biopsy-proven non-alcoholic fatty liver disease
Wiscombe, Sarah
Newton, Julia
Day, Christopher
Gibson, John
West, Sophie
[J]. SLEEP MEDICINE, 2015, 16 (08) : 1026 - 1026
[7] Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany
Labenz, Christian
Huber, Yvonne
Kalliga, Eva
Nagel, Michael
Ruckes, Christian
Straub, Beate K.
Galle, Peter R.
Woerns, Marcus-Alexander
Anstee, Quentin M.
Schuppan, Detlef
Schattenberg, Joern M.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1109 - 1116
[8] Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease
Naimimohasses, Sara
O'Gorman, Philip
McCormick, Emma
Ferguson, Damien
Monaghan, Ann
McGrath, Marie
Robinson, Mark W.
Gormley, John
Norris, Suzanne
[J]. BMJ OPEN GASTROENTEROLOGY, 2022, 9 (01):
[9] Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease
Celikbilek, Mehmet
Gursoy, Sebnem
Deniz, Kemal
Karaman, Ahmet
Zararsiz, Gokmen
Yurci, Alper
[J]. PLATELETS, 2013, 24 (03) : 194 - 199
[10] Characterization of Patients with Biopsy-Proven Non-Alcoholic Fatty Liver Disease and Normal Aminotransferase Levels
Ulasoglu, Celal
Enc, Feruze Yilmaz
Kaya, Eda
Yilmaz, Yusuf
[J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (04) : 427 - 431

← 1 2 3 4 5 →